All
RSSArticles
-
Insulin Therapy for Type 2 Diabetes: Social, Psychological, and Clinical Factors
The choices for insulin therapy are ever increasing with the development of new products that provide greater flexibility, greater range of effectiveness, lower risk of hypoglycemia, and lower pharmacokinetic and pharmacodynamic variability. These allow for individualization of treatment to match a patient’s daily life but typically at greater cost. This article will review the psychological, social, and clinical factors pertaining to the various insulin products, as well as strategies to initiate and intensify insulin therapy, to help clinicians supplement and enhance their clinical practices in diabetes management.
-
Outside Counsel Can Be the Right Choice, but Know When
Outside counsel can be an important resource for hospitals and health systems, but knowing when it is right to bring in someone can be difficult.
-
OHRP Issues Guidance on Public Health Surveillance vs. Research
The Office for Human Research Protections recently published new draft guidance to clarify the difference between human research that might require IRB review and public health surveillance that is not defined as research.
-
IRBs Can Learn to Deal With Medical Innovation Ambiguity
The lines between research and medical innovation can be blurry. When does a new surgical practice cross from case study to a study that must adhere to human research protection regulations?
-
IRB Overhauls Its Minutes Template, Saving Time and Reducing Words
Before the revision, 23% of minutes were sent out within the same week as the IRB meeting. Now, 63% of minutes are sent out during the same week.
-
Children’s Hospital Improves Assent-Consent With Animation Board Video
When a children’s hospital needed to approach research informed consent and pediatric assent with more creativity and flair, the research office asked children for input.
-
HIV Research Poses Unique Ethical Issues
When IRBs review HIV studies, particularly those aimed at finding a cure to the disease, there are some tricky ethical challenges that might not be seen in other types of research.
-
HIV Cure Research Includes Tricky Ethical Challenges
Some geneticists compared the work by He Jiankui of the Southern University of Science and Technology in Shenzhen, China, to the pioneering in vitro fertilization efforts that resulted in the birth of Louise Brown in 1978. Many others criticized the scientist for the ethical issues his experiment raised.
-
Informed Consent Rule Changes Could Help IRBs, Expand Research
The FDA has issued a proposed rule that some say would provide research institutions with much-needed clarity on informed consent regulations and open the door to clinical breakthroughs.
-
Burnout Intervention Dramatically Reduced ICU Turnover
A recent study paints a clear picture of the financial impact on hospitals if burnout goes unaddressed.